In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance - Gastroenterology
Selective targeting of point-mutated KRAS through artificial microRNAs | PNAS
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
KRAS Mutation Detection Kit_Amoydx
Hotel Kras, Jedovnice | 2022 Updated Prices, Deals
Hotel Kras, Jedovnice | 2022 Updated Prices, Deals
Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing | PLOS ONE
KRAS - Wikipedia
Defining and Targeting Adaptations to Oncogenic KRASG12C Inhibition Using Quantitative Temporal Proteomics - ScienceDirect
KRAS Mutation Detection | Trimgen
Selective targeting of point-mutated KRAS through artificial microRNAs | PNAS
KRAS inhibitors, approved | Nature Cancer
KRAS-Variant Testing - MiraDx
cobas® KRAS Mutation Test | Roche Molecular Diagnostics
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer: Cell
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS - ScienceDirect
Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors | Cell Communication and Signaling | Full Text
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors | Nature Communications
High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells - ScienceDirect
Sotorasib for Lung Cancers with KRAS p.G12C Mutation | NEJM
KRAS G12C Drug Development: Discrimination between Switch II Pocket Configurations Using Hydrogen/Deuterium-Exchange Mass Spectrometry - ScienceDirect
KRAS Mutation Detection Kit_Amoydx
Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRASG13D mutation | British Journal of Cancer
Frontiers | Recombinant KRAS G12D Protein Vaccines Elicit Significant Anti-Tumor Effects in Mouse CT26 Tumor Models | Oncology
Exceptionally high-affinity Ras binders that remodel its effector domain - Journal of Biological Chemistry
